{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
NCT02812043: Phase 4 Interventional Completed Non-dermatophyte Onychomycosis
(2016)
Source URL:
First approved in 2024
Source:
M005
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
Amorolfine (or amorolfin), is a morpholine antifungal drug with broad spectrum of activity. Its fungicidal action is based on an alteration of the fungal cell membrane targeted primarily on sterol biosynthesis. Amorolfine is administered as a nail lacquer in patients suffering from onychomycosis, as a cream in patients suffering from dermatomycosis. Amorolfine is well tolerated. The local adverse effects observed were mainly burning and itching.
Status:
Possibly Marketed Outside US
Source:
Antiperspirant ODABAN by Ryma-Pharm GmbH
(2024)
Source URL:
First approved in 2024
Source:
Antiperspirant ODABAN by Ryma-Pharm GmbH
Source URL:
Class (Stereo):
CHEMICAL (EPIMERIC)
Status:
Possibly Marketed Outside US
Source:
M017
(2024)
Source URL:
First approved in 2024
Source:
M017
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Status:
Possibly Marketed Outside US
Source:
Ferrous Sulfate by PD-Rx Pharmaceuticals, Inc.
(2024)
Source URL:
First approved in 2024
Source:
Ferrous Sulfate by PD-Rx Pharmaceuticals, Inc.
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
M022
(2024)
Source URL:
First approved in 2024
Source:
M022
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Status:
Possibly Marketed Outside US
Source:
ANDA076239
(2024)
Source URL:
First approved in 2024
Source:
ANDA076239
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
NIWEDAH SHILAJIT ASHWAGANDHA RHODIOLA ROSEA PANAXGINSENG by Shenzhen Xiaomai Manufacturing Co., Ltd.
(2024)
Source URL:
First approved in 2024
Source:
NIWEDAH SHILAJIT ASHWAGANDHA RHODIOLA ROSEA PANAXGINSENG by Shenzhen Xiaomai Manufacturing Co., Ltd.
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
